-
Kenya's economy faces climate change risks: World Bank
-
VW stops production at German site for first time
-
Rome's new Colosseum station reveals ancient treasures
-
EU eases 2035 combustion-engine ban to boost car industry
-
US unemployment rises further, hovering at highest since 2021
-
Shift in battle to tackle teens trapped in Marseille drug 'slavery'
-
Stocks retreat on US jobs, oil drops on Ukraine hopes
-
Stocks retreat ahead of US jobs, oil drops on Ukraine hopes
-
EU set to drop 2035 combustion-engine ban to boost car industry
-
Elusive December sun leaves Stockholm in the dark
-
Thousands of glaciers to melt each year by mid-century: study
-
China to impose anti-dumping duties on EU pork for five years
-
Nepal starts tiger census to track recovery
-
Economic losses from natural disasters down by a third in 2025: Swiss Re
-
Kenyan girls still afflicted by genital mutilation years after ban
-
Men's ATP tennis to apply extreme heat rule from 2026
-
Bank of Japan expected to hike rates to 30-year high
-
EU to unveil plan to tackle housing crisis
-
EU set to scrap 2035 combustion-engine ban in car industry boost
-
Asian markets retreat ahead of US jobs as tech worries weigh
-
Famed Jerusalem stone still sells despite West Bank economic woes
-
Will OpenAI be the next tech giant or next Netscape?
-
Eastman, AstraZeneca, Kraft Heinz, and P&G Recognized with OMP Supply Chain Awards
-
French minister urges angry farmers to trust cow culls, vaccines
-
Rob Reiner's death: what we know
-
Stock market optimism returns after tech selloff but Wall Street wobbles
-
Nobel winner Machado suffered vertebra fracture leaving Venezuela
-
Stock market optimism returns after tech sell-off
-
'Angry' Louvre workers' strike shuts out thousands of tourists
-
Showdown looms as EU-Mercosur deal nears finish line
-
Eurovision 2026 will feature 35 countries: organisers
-
German shipyard, rescued by the state, gets mega deal
-
'We are angry': Louvre Museum closed as workers strike
-
Stocks diverge ahead of central bank calls, US data
-
Louvre Museum closed as workers strike
-
Australia defends record on antisemitism after Bondi Beach attack
-
EU-Mercosur trade deal faces bumpy ride to finish line
-
Asian markets drop with Wall St as tech fears revive
-
France's Bardella slams 'hypocrisy' over return of brothels
-
Tokyo-bound United plane returns to Washington after engine fails
-
Deja vu? Trump accused of economic denial and physical decline
-
China's smaller manufacturers look to catch the automation wave
-
Hungary winemakers fear disease may 'wipe out' industry
-
Campaigning starts in Central African Republic quadruple election
-
'Stop the slaughter': French farmers block roads over cow disease cull
-
First urban cable car unveiled outside Paris
-
Why SpaceX IPO plan is generating so much buzz
-
US unseals warrant for tanker seized off Venezuelan coast
-
World stocks mostly slide, consolidating Fed-fuelled gains
-
Crypto firm Tether bids for Juventus, is quickly rebuffed
| CMSC | 0.21% | 23.35 | $ | |
| SCS | 0.12% | 16.14 | $ | |
| CMSD | -0.06% | 23.35 | $ | |
| BCC | 1.59% | 76.545 | $ | |
| NGG | -0.71% | 75.492 | $ | |
| RIO | 0.43% | 76.15 | $ | |
| BTI | -0.48% | 57.465 | $ | |
| RYCEF | -1.71% | 14.65 | $ | |
| GSK | -0.65% | 48.92 | $ | |
| AZN | -0.83% | 90.805 | $ | |
| RBGPF | 4.1% | 81 | $ | |
| VOD | 0.17% | 12.721 | $ | |
| RELX | -0.44% | 40.9 | $ | |
| BP | -3.59% | 34.03 | $ | |
| JRI | -0.17% | 13.537 | $ | |
| BCE | -0.25% | 23.55 | $ |
Kyrgyzstan struggles with deadly shortages of medicine
Like many people affected by serious illness in ex-Soviet Central Asia, Almagul Ibrayeva is having trouble finding medicine in her native Kyrgyzstan.
"Women are dying because of a lack of medicine," Ibrayeva, who is in her 50s, told AFP.
In remission from breast cancer, Ibrayeva needs a hormone treatment called exemestane after having a mastectomy and her reproductive organs were removed.
She said she "often" faces difficulties.
"I order it from Turkey or Moscow, where my daughter lives," she said.
"There are many medicines that are simply unavailable here. The patient has to look themselves and buy them."
- 'Meagre' supply of medicine -
Shortages, high prices and the poor quality of medicine affect many of the region's 80 million inhabitants.
The five Central Asian countries are highly dependent on pharmaceutical imports and patients are often left to fend for themselves.
There are often cases of expired or adulterated medicine such as the cough syrup imported from India which killed 69 children in Uzbekistan in 2023.
The costs of high-quality medicine are often prohibitive.
"Some people sell their homes, their livestock, get into debt just to survive," said Shairbu Saguynbayeva, a uterine cancer survivor.
She created a centre called "Together to Live" in the Kyrgyz capital Bishkek which hosts women who have cancer, offering accommodation and help for treatment.
"Here they can get organised. When someone is receiving chemotherapy, they fall ill, not every loved one can handle it," Saguynbayeva said.
Women at the centre sew and sell traditional Kyrgyz ornaments -- funding the treatment of 37 patients since 2019.
Saguynbayeva says she is grateful to the Kyrgyz state for "finally" starting to supply more medicine but says the quantity is still "meagre".
One patient, Barakhat Saguyndykova, told AFP that she received "free anti-cancer medicine only three times between 2018 and 2025".
At the National Oncology and Haematology Centre, doctor Ulanbek Turgunbaev said that sourcing medicine was "a very serious problem for patients" even though medicine supply has increased.
He said the best way of reducing therapy costs was "early detection" of serious illnesses.
- 'Better to save a mother' -
Material deficits and a shortage of 5,000 health professionals in Kyrgyzstan mean that the most urgent needs have to be addressed first.
President Sadyr Japarov has promised to eliminate corruption in the medical sector, which cost the health minister his job last winter.
While medicine factories have finally been opened, the situation in the short term remains complicated.
The Kyrgyz Chamber of Commerce and Industry said that "around 6,000 medicines could disappear from the market by 2026" because of the need to "re-register under the norms of the Eurasian Economic Union" -- a gathering of former Soviet republics including Kyrgyzstan.
The government in 2023 created a state company called Kyrgyz Pharmacy which is supposed to centralise medicine requests and bring down prices, according to its head, Talant Sultanov.
But the organisation has been under pressure because of a lack of results.
Sultanov said he hoped medicine prices could be lowered "by signing more long-term agreements with suppliers through purchases grouped on a regional basis" with other Central Asian countries.
Kyrgyz Pharmacy has promised steady supplies soon but many women in Bishkek are still waiting for medicine ordered through the company months ago.
Recently a mother of three "died simply because she did not receive her medicine in time," Saguynbayeva said.
"It is better to save a mother than to build orphanages," she said.
L.Peeters--CPN